ArticleBone2026
Sites of non-enzymatic crosslinks pentosidine and glucosepane in collagen I of human cortical bone.
Article in Bone, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Structural alterations of bone extracellular matrix (ECM) may affect bone quality, which, along with bone mass, affects the ability of bone to resist fracture. In particular, an increase in advanced glycation end-product (AGE) crosslinking of type I collagen has been implicated in contributing to increased bone fragility in diabetes and ageing. However, the location of these crosslinks and their relative abundance is unknown, thus hindering our understanding of how AGE crosslinks impact bone quality. We analyzed physiological crosslinks, glucosepane (GN) and pentosidine (PE), in collagen I from cortical bone of 12 male and 12 female cadaveric femurs using liquid chromatography-tandem mass spectrometry. The analysis identified 11 distinct crosslinks at 8 different sites within the collagen I triple helix. Crosslinks at two sites formed only within the same collagen chain, while the remaining crosslinks formed within the same triple helical molecule and/or between different molecules of the neighboring microfibrils. Most of the GN and PE crosslinks were located to the D-periodic overlap zone of the microfibril. The relative crosslink levels varied significantly at different sites: 0.005% to 2.1% for PE and 0.06% to 24.9% for GN. Female donors had fewer crosslink sites compared to male donors. While total PE and total fAGE levels did not correlate with bone mechanical properties in the present sample size, the level of GN at one site positively correlated with ultimate stress, while the level of PE at another site negatively correlated with post-yield toughness. However, these correlations were weak, and several other correlations between site-specific GN and PE levels and these mechanical properties were not consistent between the sexes. ln conclusion, this study identified the native locations of GN and PE within collagen I of bone, an innovation essential for addressing the question of how the specific structural features of bone ECM affect bone quality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.